These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 28776579)
21. Malignant Peripheral Nerve Sheath Tumor of the Femur: A Rare Diagnosis Supported by Complete Immunohistochemical Loss of H3K27me3. Sugawara M; Kobayashi E; Asano N; Yoshida A; Kawai A Int J Surg Pathol; 2017 Oct; 25(7):629-634. PubMed ID: 28508686 [TBL] [Abstract][Full Text] [Related]
22. Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status. Makise N; Sekimizu M; Kubo T; Wakai S; Hiraoka N; Komiyama M; Fukayama M; Kawai A; Ichikawa H; Yoshida A Am J Surg Pathol; 2018 May; 42(5):656-664. PubMed ID: 29309298 [TBL] [Abstract][Full Text] [Related]
23. Malignant peripheral nerve sheath tumor (MPNST) and MPNST-like entities are defined by a specific DNA methylation profile in pediatric and juvenile population. Patrizi S; Miele E; Falcone L; Vallese S; Rossi S; Barresi S; Giovannoni I; Pedace L; Nardini C; Masier I; Abballe L; Cacchione A; Russo I; Di Giannatale A; Di Ruscio V; Salgado CM; Mastronuzzi A; Ciolfi A; Tartaglia M; Milano GM; Locatelli F; Alaggio R Clin Epigenetics; 2024 Jan; 16(1):9. PubMed ID: 38178234 [TBL] [Abstract][Full Text] [Related]
24. Protein gene product 9.5 (PGP 9.5) is not a specific marker of neural and nerve sheath tumors: an immunohistochemical study of 95 mesenchymal neoplasms. Campbell LK; Thomas JR; Lamps LW; Smoller BR; Folpe AL Mod Pathol; 2003 Oct; 16(10):963-9. PubMed ID: 14559978 [TBL] [Abstract][Full Text] [Related]
25. The Value of H3K27me3 Immunohistochemistry in Differentiating Malignant Peripheral Nerve Sheath Tumour with Its Histologic Mimickers. Mustapar N; Zawawi MSF; Tuan Sharif SE Asian Pac J Cancer Prev; 2020 Mar; 21(3):699-705. PubMed ID: 32212796 [TBL] [Abstract][Full Text] [Related]
27. Loss of Histone H3K27 Trimethylation (H3K27me3) Expression as a Potential Diagnostic Pitfall in Sarcomatoid Carcinoma. Zilla ML; John I; Naous R Int J Surg Pathol; 2024 Sep; 32(6):1089-1094. PubMed ID: 37997394 [TBL] [Abstract][Full Text] [Related]
28. Cluster analysis of immunohistochemical profiles in synovial sarcoma, malignant peripheral nerve sheath tumor, and Ewing sarcoma. Olsen SH; Thomas DG; Lucas DR Mod Pathol; 2006 May; 19(5):659-68. PubMed ID: 16528378 [TBL] [Abstract][Full Text] [Related]
29. Morphologic and immunohistochemical features of malignant peripheral nerve sheath tumors and cellular schwannomas. Pekmezci M; Reuss DE; Hirbe AC; Dahiya S; Gutmann DH; von Deimling A; Horvai AE; Perry A Mod Pathol; 2015 Feb; 28(2):187-200. PubMed ID: 25189642 [TBL] [Abstract][Full Text] [Related]
30. HMGA proteins in malignant peripheral nerve sheath tumor and synovial sarcoma: preferential expression of HMGA2 in malignant peripheral nerve sheath tumor. Hui P; Li N; Johnson C; De Wever I; Sciot R; Manfioletti G; Tallini G Mod Pathol; 2005 Nov; 18(11):1519-26. PubMed ID: 16056249 [TBL] [Abstract][Full Text] [Related]
31. Expression of protein gene product 9.5 in epithelioid and conventional malignant peripheral nerve sheath tumors. Hoang MP; Sinkre P; Albores-Saavedra J Arch Pathol Lab Med; 2001 Oct; 125(10):1321-5. PubMed ID: 11570907 [TBL] [Abstract][Full Text] [Related]
32. H3K27 trimethylation loss in malignant peripheral nerve sheath tumor: a systematic review and meta-analysis with diagnostic implications. Lu VM; Marek T; Gilder HE; Puffer RC; Raghunathan A; Spinner RJ; Daniels DJ J Neurooncol; 2019 Sep; 144(3):433-443. PubMed ID: 31342317 [TBL] [Abstract][Full Text] [Related]
33. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Lee W; Teckie S; Wiesner T; Ran L; Prieto Granada CN; Lin M; Zhu S; Cao Z; Liang Y; Sboner A; Tap WD; Fletcher JA; Huberman KH; Qin LX; Viale A; Singer S; Zheng D; Berger MF; Chen Y; Antonescu CR; Chi P Nat Genet; 2014 Nov; 46(11):1227-32. PubMed ID: 25240281 [TBL] [Abstract][Full Text] [Related]
34. NY-ESO-1 expression in synovial sarcoma and other mesenchymal tumors: significance for NY-ESO-1-based targeted therapy and differential diagnosis. Lai JP; Robbins PF; Raffeld M; Aung PP; Tsokos M; Rosenberg SA; Miettinen MM; Lee CC Mod Pathol; 2012 Jun; 25(6):854-8. PubMed ID: 22388761 [TBL] [Abstract][Full Text] [Related]
36. Microphthalmia transcription factor and melanoma cell adhesion molecule expression distinguish desmoplastic/spindle cell melanoma from morphologic mimics. Koch MB; Shih IM; Weiss SW; Folpe AL Am J Surg Pathol; 2001 Jan; 25(1):58-64. PubMed ID: 11145252 [TBL] [Abstract][Full Text] [Related]
37. The diagnostic utility of reduced immunohistochemical expression of SMARCB1 in synovial sarcomas: a validation study. Ito J; Asano N; Kawai A; Yoshida A Hum Pathol; 2016 Jan; 47(1):32-7. PubMed ID: 26520417 [TBL] [Abstract][Full Text] [Related]
38. Loss of H3K27 trimethylation in a distinct group of de-differentiated chordoma of the skull base. Makise N; Shimoi T; Sunami K; Aoyagi Y; Kobayashi H; Tanaka S; Kawai A; Yonemori K; Ushiku T; Yoshida A Histopathology; 2023 Feb; 82(3):420-430. PubMed ID: 36217885 [TBL] [Abstract][Full Text] [Related]